218 related articles for article (PubMed ID: 11501221)
1. Hair as a biological specimen for therapeutic drug monitoring.
Beumer JH; Bosman IJ; Maes RA
Int J Clin Pract; 2001; 55(6):353-7. PubMed ID: 11501221
[TBL] [Abstract][Full Text] [Related]
2. Clinical benefit of interventions driven by therapeutic drug monitoring.
Rendón A; Núñez M; Jiménez-Nácher I; González de Requena D; González-Lahoz J; Soriano V
HIV Med; 2005 Sep; 6(5):360-5. PubMed ID: 16156885
[TBL] [Abstract][Full Text] [Related]
3. The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry.
Baumann P; Hiemke C; Ulrich S; Eckermann G; Gaertner I; Gerlach M; Kuss HJ; Laux G; Müller-Oerlinghausen B; Rao ML; Riederer P; Zernig G;
Pharmacopsychiatry; 2004 Nov; 37(6):243-65. PubMed ID: 15551191
[TBL] [Abstract][Full Text] [Related]
4. [Detection of antidepressant and antipsychotic drugs in human hair and evaluation of the results].
Shen M; Xiang P; Shen B; Huang Z
Fa Yi Xue Za Zhi; 2000 Aug; 16(3):148-52, 191. PubMed ID: 12536418
[TBL] [Abstract][Full Text] [Related]
5. Appropriateness of therapeutic drug monitoring for lithium.
Ratanajamit C; Soorapan S; Doang-ngern T; Waenwaisart W; Suwanchavalit L; Suwansiri S; Jantasaro S; Yanate I
J Med Assoc Thai; 2006 Nov; 89(11):1954-60. PubMed ID: 17205880
[TBL] [Abstract][Full Text] [Related]
6. Hair analysis for veterinary drug monitoring in livestock production.
Gratacós-Cubarsí M; Castellari M; Valero A; García-Regueiro JA
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Apr; 834(1-2):14-25. PubMed ID: 16564753
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic drug monitoring of antidepressants--clinical aspects.
Laux G; Baumann P; Hiemke C;
J Neural Transm Suppl; 2007; (72):261-7. PubMed ID: 17982902
[TBL] [Abstract][Full Text] [Related]
8. Hair as a biological indicator of drug use, drug abuse or chronic exposure to environmental toxicants.
Boumba VA; Ziavrou KS; Vougiouklakis T
Int J Toxicol; 2006; 25(3):143-63. PubMed ID: 16717031
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and therapeutic drug monitoring of psychotropic drugs in pediatrics.
Pichini S; Papaseit E; Joya X; Vall O; Farré M; Garcia-Algar O; de laTorre R
Ther Drug Monit; 2009 Jun; 31(3):283-318. PubMed ID: 19363463
[TBL] [Abstract][Full Text] [Related]
10. Misuse of therapeutic drug monitoring: an analysis of causes and methods for improvement.
Travers EM
Clin Lab Med; 1987 Jun; 7(2):453-72. PubMed ID: 3301179
[TBL] [Abstract][Full Text] [Related]
11. Testing human hair for carbamazepine in epileptic patients: is hair investigation suitable for drug monitoring?
Kintz P; Marescaux C; Mangin P
Hum Exp Toxicol; 1995 Oct; 14(10):812-5. PubMed ID: 8562122
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic drug monitoring in pregnancy.
Matsui DM
Ther Drug Monit; 2012 Oct; 34(5):507-11. PubMed ID: 22846897
[TBL] [Abstract][Full Text] [Related]
13. Bioanalytical issues in patient-friendly sampling methods for therapeutic drug monitoring: focus on antiretroviral drugs.
ter Heine R; Beijnen JH; Huitema AD
Bioanalysis; 2009 Oct; 1(7):1329-38. PubMed ID: 21083054
[TBL] [Abstract][Full Text] [Related]
14. [Hair analysis of abused and therapeutic drugs in forensic toxicology].
Klausz G; Kass K; Sótonyi P; Róna K
Orv Hetil; 2006 Nov; 147(45):2181-6. PubMed ID: 17402212
[TBL] [Abstract][Full Text] [Related]
15. [Therapeutic drug monitoring: clinical practice].
Widmer N; Werner D; Grouzmann E; Eap CB; Marchetti O; Fayet A; Csajka C; Decosterd LA; Buclin T
Rev Med Suisse; 2008 Jul; 4(165):1649-50, 1652-60. PubMed ID: 18767291
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacokinetics and therapeutic drug monitoring of anticancer agents].
Marquet P; Rousseau A
Bull Cancer; 2008 Oct; 95(10):903-9. PubMed ID: 19004719
[TBL] [Abstract][Full Text] [Related]
17. Value and actuality of the prescription information for therapeutic drug monitoring of psychopharmaceuticals: a comparison with the medico-scientific evidence.
Ulrich S; Hiemke C; Laux G; Müller-Oerlinghausen B; Havemann-Reinecke U; Riederer P; Zernig G; Baumann P;
Pharmacopsychiatry; 2007 May; 40(3):121-7. PubMed ID: 17541888
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic drug monitoring of tricyclic antidepressants: how does it work under clinical conditions?
Müller MJ; Dragicevic A; Fric M; Gaertner I; Grasmäder K; Härtter S; Hermann E; Kuss HJ; Laux G; Oehl W; Rao ML; Rollmann N; Weigmann H; Weber-Labonte M; Hiemke C
Pharmacopsychiatry; 2003 May; 36(3):98-104. PubMed ID: 12806567
[TBL] [Abstract][Full Text] [Related]
19. Antiepileptic drugs--best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies.
Patsalos PN; Berry DJ; Bourgeois BF; Cloyd JC; Glauser TA; Johannessen SI; Leppik IE; Tomson T; Perucca E
Epilepsia; 2008 Jul; 49(7):1239-76. PubMed ID: 18397299
[TBL] [Abstract][Full Text] [Related]
20. The impact of cytochrome P450-2D6 genotype on the use and interpretation of therapeutic drug monitoring in long-stay patients treated with antidepressant and antipsychotic drugs in daily psychiatric practice.
Mulder H; Herder A; Wilmink FW; Tamminga WJ; Belitser SV; Egberts AC
Pharmacoepidemiol Drug Saf; 2006 Feb; 15(2):107-14. PubMed ID: 16294366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
